362 related articles for article (PubMed ID: 28745230)
21. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
23. Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).
Teeranachaideekul V; Morakul B; Boonme P; Pornputtapitak W; Junyaprasert V
J Oleo Sci; 2020; 69(12):1627-1639. PubMed ID: 33268665
[TBL] [Abstract][Full Text] [Related]
24. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
26. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
Kovács A; Berkó S; Csányi E; Csóka I
Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
[TBL] [Abstract][Full Text] [Related]
27. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
28. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
29. Articaine in functional NLC show improved anesthesia and anti-inflammatory activity in zebrafish.
Rodrigues da Silva GH; Geronimo G; García-López JP; Ribeiro LNM; de Moura LD; Breitkreitz MC; Feijóo CG; de Paula E
Sci Rep; 2020 Nov; 10(1):19733. PubMed ID: 33184457
[TBL] [Abstract][Full Text] [Related]
30. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK
Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576
[TBL] [Abstract][Full Text] [Related]
33. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
34. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
Kovačević AB; Müller RH; Keck CM
Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
[TBL] [Abstract][Full Text] [Related]
35. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
Lasoń E; Sikora E; Ogonowski J
Acta Biochim Pol; 2013; 60(4):773-7. PubMed ID: 24432330
[TBL] [Abstract][Full Text] [Related]
36. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
37. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
[TBL] [Abstract][Full Text] [Related]
39. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
40. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.
Kasongo KW; Shegokar R; Müller RH; Walker RB
Drug Dev Ind Pharm; 2011 Apr; 37(4):396-407. PubMed ID: 20923388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]